PMCTPharmaCountry
    Startseite
Studien & Berichte25. Aug. 2026•1 Min. Lesezeit

Study Links Paternal Valproate Use at Conception to Neurodevelopmental Risks in Children

Vom PharmaCountry-Team

1

A study suggests valproate use by men near conception may be linked to higher risk of neurodevelopmental disorders in offspring.

A retrospective observational study has indicated a possible association between valproate use by men around the time of conception and an increased risk of neurodevelopmental disorders in their children. Inform male p…

Zusammengestellt vom PharmaCountry-Team · Quelle: MHRA

Themen:#valproate#paternal exposure#neurodevelopmental disorders#pharmacovigilance#reproductive safety

Weitere Artikel

Alle Einblicke anzeigen
Studien & Berichte
Global Finished Dosage Manufacturing Landscape 2026
5. Okt. 2026
Regulatorische Updates
Korea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28. Sept. 2026
Analyse
Pharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28. Sept. 2026